The company received complaints regarding the syringes in the kits that revealed dural puncture with some also requiring a blood patch. An inadvertent dural puncture may lead to headache, tinnitus and (rarely) intracranial hemorrhage, according to the safety notice.
IN CASE YOU MISSED IT
- Shareholder lawsuit over BD’s Alaris pumps recall moves forward
- Embecta stock soars on first full-quarter results after BD spinoff
- Abbott will spend $450M to up FreeStyle Libre production in Ireland
- Better Therapeutics Q2 beats Street as it prepares to submit diabetes therapy for FDA review
- Study backs Fluidx embolic device for vessel filling